Publisher： John Wiley & Sons Inc
E-ISSN： 2055-2335|34|2|100-103
ISSN： 1445-937x
Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.34, Iss.2, 2004-06, pp. : 100-103
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Barriers to the uptake of new high-cost cancer drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Access to resources
Recommend
EU evaluation of high-cost orphan drugs urged
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. :
Access to High‐Cost Drugs: Decision Makers' Perspectives
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 1, 2005-03 ,pp. :
Biopharmaceuticals a high-cost gamble
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 11, 2006-01 ,pp. :
Prescribing of high-cost diabetes medications lacks consistency
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. :